In the p53 pathway, signals such as DNA damage induce the ARF (also known as p14 in humans and p19 in mice) product of the CDKN2A locus. ARF increases p53 levels by sequestering MDM2, which ...
The researchers discovered that cells that were at risk of developing cancer but lost both p53 and CDKN2A were weaker and less able to compete with nearby cells, which stopped cancer from spreading.
Loss of p53 strongly drives the progression of disease from Barrett’s to cancer. The team found that potentially cancerous cells that lost both CDKN2A and p53 were weakened and unable to compete ...
In case of CDKN1A (1:50, MA5-14949, Live Technologies), CDKN2A (1:200, ab108349, Abcam), and p53 (1:100, LS-B7723, LSBio, Shirley, USA) antigens were demasked with 10 mM citrate buffer (16 h, 65°C).